Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference
Department of Medicine, Division of Cardiovascular Medicine
Cardiovascular Diseases; *Health Behavior; Humans; Models, Psychological; *Patient Compliance; Preventive Medicine; Risk Factors
Cardiology | Cardiovascular Diseases
Adherence (equivalent to compliance) to lifestyle and medication recommendations for the prevention of cardiovascular disease (CVD) is a crucial element in the path from the science of risk-factor modification to the actual reduction of risk factors and consequent prevention of disease-related events. This Task Force Report presents an overview of the evidence supporting multilevel strategies for improving the adherence to lifestyle and pharmacologic interventions. Building on available adherence data and consistent with the theme of this Bethesda Conference, suggestions for advancing CVD prevention on both an individual and population level are also offered.
J Am Coll Cardiol. 2002 Aug 21;40(4):630-40.
Journal of the American College of Cardiology
Ockene IS, Hayman LL, Pasternak RC, Schron E, Dunbar-Jacob J. (2002). Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. Cardiovascular Medicine Publications. Retrieved from https://escholarship.umassmed.edu/cardio_pp/13